The Ashkenazi connection

Among individuals of Eastern European (or Ashkenazi) Jewish descent, incidence of Type 1 Gaucher disease is considerably higher (as many as 1 in 450 people) than in the general population (1 in 40,000-60,000).

Approximately 1 in every 12 to 15 Ashkenazi people is a carrier. As a result, genetic counselling and/or carrier testing for Gaucher disease may be appropriate for people of Ashkenazi descent to help determine risk and reproductive choices.

Please check back regularly for updates

Genzyme Australiasia Pty Ltd

Level 1, Building C,
12-24 Talavera Road
North Ryde NSW 2113
P: 612 9978 3900
F: 612 9889 3900

Mailing Address:
PO Box 282
North Ryde B/C NSW 1670